{"brief_title": "Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia", "brief_summary": "The purpose of the protocol is to evaluate the efficacy of olanzapine compared with Aripiprazole in patients with schizophrenia.", "condition": "Schizophrenia", "intervention_type": "Drug", "intervention_name": "Aripiprazole", "criteria": "Inclusion Criteria: - Male or female inpatient or outpatients, ages 18-65 Exclusion Criteria: - Participation in a clinical trial of another drug including olanzapine or aripiprazole within 30 days prior to study entry (visit 1). - Treatment with clozapine within the past 12 months. - Have known uncorrected narrow-angle glaucoma. - Have a diagnosis of Parkinson's disease, dementia or related disorder", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "id": "NCT00088049.xml"}